«Back

Class 4 Caution in Use on Emerade 150, 300, 500 Micrograms Pfs

Class 4 Caution in Use on Emerade 150, 300, 500 Micrograms Pfs

Bausch & Lomb UK limited has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
3849221 EMERADE 150 AUTO-INJECTOR BAUSCH & LOMB UK ALL STOCK
3849239 EMERADE 300 AUTO-INJECTOR BAUSCH & LOMB UK ALL STOCK
3849247 EMERADE 500 AUTO-INJECTOR BAUSCH & LOMB UK ALL STOCK

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

For stock enquiries please contact Bausch & Lomb Customer Services: Tel: 0208 781 2991 Email: Pharma_CS@bausch.com.

For medical information enquiries please contact Lizanne Kombrink, Pharmacovigilance and Medical Information Officer: Tel: 0208 781 5523 Email: Pharmacovigilance.UK@bausch.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.